|
|
| | |
 |
|
| Thursday,
September 16, 2010 09.30-17.30 | | Auditorium
2 | | |
| Decision
Making in Low- and High-grade Gliomas | | Evidence
or Emotion Based? | | Moderator:
Charles J. Vecht | | |
| 09.00
- 09.30 | Coffee | | | Diagnosis
and therapy: state-of-the-art | | 09.30
- 09.45 | Setting the stage: What is evidence?,
P.Leffers | | 09.45 - 09.55 |
Clinical Case part 1: Low grade glioma, D.Brandsma | | 09.55
- 10.20 | Integrating MRI in the decision making:
when to stop "wait and see" in low - grade glioma, A.Waldman | | | |
| Evolution
to high grade glioma |
| 10.20 - 10.45 | Neuropathological
diagnosis, P.Wesseling | | 10.45
- 11.10 | Neurosurgery, C.Dirven | | 11.10
- 11.40 | Coffee break | | 11.40
- 11.45 | Clinical Case part 2: glioblastoma,
D.Brandsma | | 11.45 - 12.10 |
Radiotherapy: The cornerstone of glioma treatment, L.Stalpers | | 12.10
- 12.35 | Chemotherapy, M.van den Bent | | 12.35
- 13.00 | Cognition, J.Heimans | | 13.00
- 14.00 | Lunch |
| 14.00 - 14.10 |
Clinical Case part 3: tumour recurrence, D.Brandsma | | 14.10
- 14.35 | Recurrence vs. pseudo-progression, S.Sunaert | | 14.35
- 15.00 | The role of re-operation in malignant glioma, P.Vandertop | | 15.00
- 15.25 | Efficacy of re-irradiation, B.Baumert | | 15.25
- 15.50 | Experimental therapy I, A.Griffioen | | 15.50
- 16.20 | Coffee break | | 16.20
- 16.25 | Clinical Case part 4: tumour re-recurrence,
D.Brandsma | | 16.25 - 16.50 |
Experimental therapy II / Patient shopping, W.van der Graaf | | 16.50
- 17.15 | Quality of Life and Quality of Care
in the End-of-Life phase, M.Taphoorn | | 17.15
- 17.30 | Conclusions & Discussion: evidence,
emotion, reason, P.Leffers | | 17.30 |
Closure | | | |
|
|
